Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-cell mass cytometric analysis of peripheral immunity and multiplex plasma marker profiling of non-small cell lung cancer patients receiving PD-1 targeting immune checkpoint inhibitors in comparison with platinum-based chemotherapy.
Neuperger P, Szalontai K, Gémes N, Balog JÁ, Tiszlavicz L, Furák J, Lázár G, Puskás LG, Szebeni GJ. Neuperger P, et al. Front Immunol. 2023 Oct 13;14:1243233. doi: 10.3389/fimmu.2023.1243233. eCollection 2023. Front Immunol. 2023. PMID: 37901220 Free PMC article.
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.
Szebeni GJ, Gémes N, Honfi D, Szabó E, Neuperger P, Balog JÁ, Nagy LI, Szekanecz Z, Puskás LG, Toldi G, Balog A. Szebeni GJ, et al. Among authors: neuperger p. Front Immunol. 2022 Mar 31;13:846248. doi: 10.3389/fimmu.2022.846248. eCollection 2022. Front Immunol. 2022. PMID: 35432314 Free PMC article.
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2.
Szabó E, Modok S, Rónaszéki B, Faragó A, Gémes N, Nagy LI, Hackler L Jr, Farkas K, Neuperger P, Balog JÁ, Balog A, Puskás LG, Szebeni GJ. Szabó E, et al. Among authors: neuperger p. Front Med (Lausanne). 2023 Jul 17;10:1176168. doi: 10.3389/fmed.2023.1176168. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37529238 Free PMC article.
Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.
Balog JÁ, Hackler L Jr, Kovács AK, Neuperger P, Alföldi R, Nagy LI, Puskás LG, Szebeni GJ. Balog JÁ, et al. Among authors: neuperger p. Int J Mol Sci. 2019 Dec 25;21(1):170. doi: 10.3390/ijms21010170. Int J Mol Sci. 2019. PMID: 31881770 Free PMC article.
Analysis of the Single-Cell Heterogeneity of Adenocarcinoma Cell Lines and the Investigation of Intratumor Heterogeneity Reveals the Expression of Transmembrane Protein 45A (TMEM45A) in Lung Adenocarcinoma Cancer Patients.
Neuperger P, Balog JÁ, Tiszlavicz L, Furák J, Gémes N, Kotogány E, Szalontai K, Puskás LG, Szebeni GJ. Neuperger P, et al. Cancers (Basel). 2021 Dec 29;14(1):144. doi: 10.3390/cancers14010144. Cancers (Basel). 2021. PMID: 35008313 Free PMC article.
13 results